{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:17:15Z","timestamp":1790414235449,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/j.thromres.2003.08.003","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T19:45:58Z","timestamp":1066160758000},"page":"355-359","source":"Crossref","is-referenced-by-count":48,"title":["Role of antiplatelet drugs in the prevention of cardiovascular events"],"prefix":"10.1016","volume":"110","author":[{"given":"Micha\u0142","family":"Tendera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Wojakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2003.08.003_BIB1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2003.08.003_BIB2","doi-asserted-by":"crossref","first-page":"228S","DOI":"10.1378\/chest.119.1_suppl.228S","article-title":"Antithrombotic agents in coronary artery disease","volume":"119","author":"Cairns","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2003.08.003_BIB3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMcp012672","article-title":"Aspirin for primary prevention of coronary events","volume":"346","author":"Lauer","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2003.08.003_BIB4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00001573-200209000-00017","article-title":"Aspirin in the prophylaxis of coronary artery disease","volume":"17","author":"Mehta","year":"2002","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.thromres.2003.08.003_BIB5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.CIR.0000021112.29409.A2","article-title":"Need to test the inflammation hypothesis","volume":"106","author":"Bhatt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0735-1097(02)02006-5","article-title":"Optimizing the diabetic formulary: beyond Aspirin and Insulin","volume":"40","author":"Marso","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2003.08.003_BIB8","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"PlA2 polymorphism of \u03b23 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.HDX.0000061697.22030.e5","article-title":"Clopidogrel in the management of ischemic heart disease","volume":"5","author":"Cavusoglu","year":"2003","journal-title":"Heart Dis."},{"key":"10.1016\/j.thromres.2003.08.003_BIB11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2003.08.003_BIB12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0735-1097(01)01713-2","article-title":"Meta-analysis of randomized and registry comparisons of ticlopidine and clopidogrel after stenting","volume":"39","author":"Bhatt","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2003.08.003_BIB13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine after placement of coronary-artery stents","volume":"101","author":"Muller","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc3001.093435","article-title":"Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population","volume":"104","author":"Taniuchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0735-1097(02)02974-1","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine after placement of coronary-artery stents","volume":"41","author":"Muller","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2003.08.003_BIB17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.CIR.0000065125.50640.70","article-title":"Are antiplatelet effects of clopidogrel inhibited by atorvastatin?","volume":"107","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.CIR.0000019581.22812.B2","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors. Recognition of a two-edged sword?","volume":"106","author":"Quinn","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.08.003_BIB19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00129784-200101060-00002","article-title":"Oral glycoprotein IIb\/IIIa inhibitors. Why don't they work?","volume":"1","author":"Chew","year":"2001","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.thromres.2003.08.003_BIB20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9343(02)01106-3","article-title":"The failure of orally administered glycoprotein IIb\/IIIa inhibitors to prevent recurrent cardiac events","volume":"112","author":"Newby","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2003.08.003_BIB21","first-page":"670","article-title":"Glycoprotein IIb\/IIIa receptor number and occupancy during chronic administration of an oral antagonist","volume":"295","author":"Quinn","year":"2000","journal-title":"JPET"},{"key":"10.1016\/j.thromres.2003.08.003_BIB22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00129784-200303020-00004","article-title":"The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb\/IIIa receptor inhibitor, in patients with stable coronary artery disease","volume":"3","author":"Murphy","year":"2003","journal-title":"Am. J. Cardiovasc. Drugs"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384803004225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384803004225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T20:10:58Z","timestamp":1553717458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384803004225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":22,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0049384803004225"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2003.08.003","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}